Mitsui Global Investment
Venture capitalMenlo Park · Pre-Seed–Late Stage · 12 people tracked
Also known as MITSUI & CO. GLOBAL INVESTMENT, INC. · Mitsui & Co. Global Investment, Inc. 東京支店
Investment thesis
The firm positions itself as an investor that goes beyond financial backing, actively guiding entrepreneurs with strong business plans and ambitious goals. It partners with exceptional teams reinventing industries to improve human welfare worldwide, and emphasizes involvement in local communities alongside a global growth orientation. The firm highlights portfolio companies that have overcome setbacks and market challenges to grow stronger.
Source: firm website, verified Aug 25, 2026.
Team · 12 people
from the firm's website & public directoriesWhat they invest in
from 23 of 61 portfolio companiesBiotech ×13Healthtech ×6AI & Machine Learning ×5Deep Tech ×4Medical Devices ×4Cleantech ×3Digital Health ×3Climate Tech ×2
HQs:United States×23Japan×1
Who they back
founder profiles across 14 portfolio companiesFounding team size:solo founder×72 founders×33 founders×34+ founders×1
Investments · 61 tracked
founders shown can be your intro pathBy year:2023 · 12018 · 12017 · 12015 · 12014 · 12012 · 27 dated
Kaltura provides AI-powered video platforms for live and on-demand digital experiences that enable brands and organizations to engage audiences and achieve business goals.
AI & Machine LearningEnterprise SoftwareMedia & EntertainmentNew York, US
Ron Yekutiel(Founder)
Co-investors.406 VenturesAvalon Ventures Management, LlcLuminari CapitalNGP CapitalRuna CapitalSapphire Ventures+3 more
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
BiotechHealthtechNew Haven, US
Steve Uden(Co-Founder & Chief Executive Officer)Stephen Uden(Founder)inMartin(Co-Founder & Chairman)Jon(Chief Financial Officer)
Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsF-Prime CapitalSolasta Ventures
NYSE-listed Spire Global operates a constellation of RF-sensing nanosatellites and sells space-based data, analytics and space services.
Vienna, US
Theresa Condor(Executive Officer, Director)Peter Platzer(Executive Officer, Director)Joan Amble(Director)William Porteous(Director)Celia Perez Pelaz(Executive Officer)Dirk Hoke(Director)
Israeli fabless chipmaker behind HDBaseT and MIPI A-PHY connectivity chipsets for audio-video and automotive systems.
Biopharmaceutical company developing therapeutics for respiratory and inflammatory disorders such as asthma and rheumatoid arthritis.
Biotech developing small-molecule therapies for respiratory, inflammatory and autoimmune diseases, acquired by Boehringer Ingelheim.
BiotechSan Mateo, US
Peter McWilliams(Executive Officer, Director)Kevin Bacon(Executive Officer, Director)
BoardFred Middleton(Director)Masaji Matsuoka(Director)in
ArmaGen develops blood-brain-barrier-crossing protein therapies for lysosomal storage disorders; acquired by JCR Pharmaceuticals in 2020.
BiotechCalabasas, US
Ruben Boado(Executive Officer)William Pardridge(Director)Mathias Schmidt(Executive Officer, Director)
BoardJayson Punwani(Director)Martin Heidecker(Director)
Biotechnology company developing blood-brain-barrier-penetrating recombinant protein therapies for CNS disorders; acquired by JCR Pharmaceuticals in 2020.
Israeli fabless semiconductor company making vehicle-to-everything (V2X) communication chipsets for connected and autonomous vehicles.
Co-investorsAmiti VenturesFraser McCombs CapitalMagenta Venture PartnersManiv MobilitySamsung Catalyst Fund
Clinical-stage biotech developing redox-biology therapeutics for inherited mitochondrial disease; acquired by PTC Therapeutics.
Shanghai-based clinical-stage biopharmaceutical company developing oncology and other therapies, acquired by Servier.
Biotech developing novel cancer therapeutics targeting cancer stem cells.
Healthcare technology company providing revenue cycle management and payment processing for US providers and insurers.
Israeli developer of edge-based computer vision driver and occupancy monitoring systems for automakers and fleets.
ContinuumRx forms joint ventures with health systems to deliver home infusion and specialty pharmacy services.
Ellipsis is a cloud platform that lets engineering teams deploy and govern fleets of AI coding agents.
Boston-area biotech using its Kinetic Ensemble computational and AI platform to design small molecules for difficult-to-drug oncology targets.
Shanghai-based mobile marketing company operating an SMS/MMS distribution platform built on a large mobile subscriber database.
goBalto is a San Francisco cloud clinical-trial site startup platform acquired by Oracle in 2018-2019.
San Francisco, US
Jae Chung(Executive Officer, Director)Sujay Jadhav(Executive Officer, Director)
BoardDarren Hite(Director)Masashi Kiyomine(Director)Lawrence Low(Director)
GoSecure is a Managed Detection and Response (MDR) cybersecurity provider based in Montreal and San Diego.
San Diego, US
Co-investorsEastward Capital PartnersRazor's Edge VenturesEdgeYaletown Partners
Chinese pharmaceutical manufacturer in Haikou producing antibiotics, ointments and gastrointestinal medicines.
Bootstrapped studio-model holding company that builds and scales SaaS products and agencies with built-in distribution.
Chinese independent automobile design firm providing vehicle R&D, powertrain and core-component development, listed on Shenzhen's GEM board.
Salt Lake City biotech applying machine learning to medicinal chemistry and large-scale compound-protein screening.
Hong Kong-based video game holding company behind Warframe developer Digital Extremes, acquired by Tencent in December 2020.
Mahzi develops therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders, working with patient and family groups, academic researchers, and industry partners.
BiotechHealthtechSouth San Francisco, US
Yael Weiss(Executive Officer, Director)in
BoardCamille Samuels(Director)inMarten Steen(Director)inShalini Sharp(Director)inStephen Farr(Director)
Co-investorsDroia VenturesHealthCapVenrockVenrock Associates
Davis, California developer of biological crop protection, plant health and waterway treatment products, formerly NASDAQ: MBII.
AgTechDavis, US
Pamela G. Marrone(Executive Officer, Director)Pamela G Marrone(Executive Officer, Director)James B. Boyd(Executive Officer)Linda V. Moore(Executive Officer)Don Glidewell(Executive Officer)Julie I Morris(Executive Officer)
Co-investorsBand of Angels
MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)
BoardMarc Singer(Director)in
Co-investorsBraemar Energy VenturesOUP (Osage University Partners)Windham Capital PartnersNorth Bridge Venture Partners
Clinical-stage biopharmaceutical company developing oligonucleotide therapeutics using an immune cell-targeted delivery platform.
BiotechBurlingame, US
BoardWalter Olesiak(Executive Officer, Director)Kazuhiko Nonomura(Director)Taro Inaba(Director)
Co-investorsRemiges Ventures, Inc.
Neura Health provides telemedicine video visits with board-certified neurologists for conditions including migraine, epilepsy, sleep disorders, tremor, concussion, and stroke.
Digital HealthHealthtechNew York, US
Sameer Madan(Founder)inElizabeth Burstein(Founder)in
Co-investorsCorrelation VenturesE12 Venture Capital, LlcKoch Disruptive TechnologiesNext Play Ventures
Early-stage ophthalmology company developing therapeutic angiogenesis treatments for retinal ischemia in age-related macular degeneration.
Medical device maker of the Rezum water-vapor system for benign prostatic hyperplasia, acquired by Boston Scientific in 2018.
Maple Grove, US
Michael Hoey(Executive Officer, Director)Patrick Fabian(Executive Officer)Maximillian Fiore(Executive Officer)J. Robert Paulson(Executive Officer, Director)Carmen L. Bringgold(Executive Officer)
BoardJan Garfinkle(Director)in
Co-investorsArboretum Ventures
Japanese developer of microfluidic-chip instruments for life sciences, including a disposable-chip cell sorter and droplet selector.
OpenX is a supply-side platform (SSP) for digital advertising that uses AI, data leadership, and proprietary identity technology to manage ad inventory and targeting.
AdTechAI & Machine LearningNot specified on page, US
DAMON REEVE(Director)TIM CADOGAN(Executive Officer, Director)
BoardNINO MARAKOVIC(Director)ANDREW Scott BRACCIA(Director)BERNARD DALLE(Director)JON MILLER(Director)
Co-investorsChartline Capital PartnersDag VenturesIndex VenturesPresidio VenturesSapphire VenturesSecond Alpha Partners+2 more
Pica8 develops PICOS, a Linux-based open network operating system, and the AmpCon controller for white box enterprise networks.
Silicon Valley developer of an ultra-efficient four-stroke, opposed-piston, sleeve-valve internal combustion engine.
Co-investorsNew Enterprise Associates (NEA)
ProteinSimple developed instruments and consumables for protein analysis; acquired by Techne/Bio-Techne for $300M in 2014.
Proterra designs and manufactures zero-emission battery systems for commercial vehicles.
CleantechHardwareMobility & TransportationGreenville, US
Ryan Popple(Executive Officer, Director)Eric McCarthy(Executive Officer)C. W. Plummer, Jr.(Executive Officer)Dave Rich(Executive Officer)Steven Rowe(Director)
BoardRob Johnson(Director)
Co-investorsBMW i VenturesConductive VenturesConstellation Technology VenturesEnergy Impact PartnersEvolution VC PartnersObvious Ventures+3 more
QD Laser develops semiconductor laser technology, including ultrashort-pulse DFB lasers for non-thermal micromachining of materials and its Visirium retinal-projection technology that projects images directly onto the retina for people with low vision.
HardwareMedical DevicesSemiconductors
Mitsuru Sugawara(Founder)in
Co-investorsBeyond Next VenturesMIRAI SOUZOUOita Venture CapitalSMBC Venture CapitalUntroD CapitalUTokyo Innovation Platform Co. Ltd.+1 more
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)Roet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)Jason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)
Co-investorsDroia VenturesMC Healthcare VenturesMission BiocapitalSanofi VenturesSV Health InvestorsAmgen Ventures+6 more
Redwood Systems, Inc. manufactures lighting products for offices, schools, data centers and hospitality use.
Reunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder.
BiotechDigital HealthMental HealthMorristown, US
Sahil V. Kirpekar(President and CEO)Gregory Mayes(Executive Officer, Director)Ellen Lubman(Director)Mark Pollack(Executive Officer)inNathan Bryson(Executive Officer)inMark Theeuwes(Executive Officer)in
Co-investorsFemHealth VenturesMPM BioImpactNovo Holdings
Streamlines hospital and industry data collaborations for AI in healthcare without compromising data privacy.
Co-investorsLionBird
Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.
AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US
Dr. Ittai DayaninYuval Baror(Founder)
Co-investorsAlleyCorpE12 Venture Capital, LlcFusionLionBirdAlley Robotics VenturesVolution Ventures
Wireless and wired networking vendor whose Wi-Fi access points, switches and management software serve carriers and enterprises.
Sunnyvale, US
William Kish(Executive Officer, Director)Victor Shtrom(Executive Officer)Selina Lo(Executive Officer, Director)James Hennessy(Executive Officer)
BoardGaurav Garg(Director)Mohan Gyani(Director)
Co-investorsWingSequoia Capital
Focuses on discovery and clinical development of targeted cancer drugs.
Singapore-based biotech developing targeted small molecule cancer drugs, with lead HDAC and kinase programs including JAK2 inhibitor pacritinib.
Silk (formerly Kaminario) offers a software-defined SAN that acts as a cloud acceleration layer for mission-critical applications.
Sirrus develops chemical building blocks based on patented methylene malonate monomers and oligomeric crosslinkers that polymerize anionically at ambient temperatures.
Advanced ManufacturingCleantechDeep TechNew MaterialsLoveland, US
Bernard Malofsky(Executive Officer)Jeff Uhrig(President, Chief Executive Officer, Secretary and Treasurer)Robert Smith(Executive Officer)Adam Malofsky(Director)
BoardWilliam Lese(Director)inDoug Cameron(Director)
Co-investorsBraemar Energy VenturesCincyTechArsenal
Beijing-based operator of an online entertainment platform connecting amateur performers with their fans.
Spire operates a constellation of nanosatellites that collect granular Earth and environmental data from orbit, providing analytics for climate, logistics, and community protection.
Climate TechData & InfrastructureLogistics & Supply ChainSpace TechVienna, Virginia, US
Peter Platzer(Founder)inJeroen Cappaert(Founder)inJoel Spark(Founder)
Co-investorsBessemer Venture PartnersEvolution VC PartnersExpon CapitalFresco CapitalGPO FundGrishin Robotics+6 more
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.
AI & Machine LearningBiotechMedical Devices
Co-investorsAIX VenturesFoothill VenturesAxial VCBoxOne VenturesCaffeinated CapitalDimension Capital+1 more
Svante makes solid-sorbent filters and modular machines that capture and remove CO2 from industrial flue gas and the air, concentrating it to pipeline-grade purity for storage or reuse.
CleantechClimate TechEnergyNew MaterialsBurnaby
Matthew Stevenson(Executive Officer)Claude Letourneau(Executive Officer)
BoardMarc Van Den Berg(Director)Roger Strauch(Director)inDamien Vacherot(Director)Laura Boudreau(Director)
Co-investorsBay Bridge Ventures ClimateChrysalixClimate InvestmentInBC Investment Corp.TechEnergy VenturesThe Roda Group
Biotechnology company developing therapeutics that target the extracellular matrix in acute and chronic diseases.
BiotechSan Francisco, US
KENNETH N. HORNE(Executive Officer, Director)ALYSSA PANITCH(Director)JOHN PADERI(Director)KATE STUART(Executive Officer)
Co-investorsAlly Bridge GroupInCube VenturesLilly Ventures
Tacit develops RNA repair technology called Splicing-Directed Repair, which uses naturally-occurring biological systems to fix genetic mutations as an alternative to conventional gene editing.
BiotechDeep TechHealthtech
Co-investorsEisai Innovation, Inc.KdT Ventures
Therini Bio is a biotechnology company developing therapies that block vascular-mediated inflammation to halt chronic neurological disease.
BiotechHealthtechSacramento, US
Laia Crespo-Martin(Director)Leslie Schulze(Executive Officer)Daniel D Burgess(Director)Michael Ross(Director)Tara Nickerson(Executive Officer, Director)
BoardOlga Danilchanka(Director)
Co-investorsAngelini VenturesMRL Ventures FundSanofi VenturesSV Health InvestorsApollo Health VenturesDementia Discovery Fund+1 more
Virident Systems built PCIe server-side flash storage products for enterprise, virtualization and cloud datacenters.
Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.
AI & Machine LearningBiotechDeep Tech
Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in
Co-investorsAmplify PartnersFifty YearsHummingbird VenturesMBX CapitalRecode VenturesAmplify Partners CV+2 more
Exits · 5
IPOs and acquisitions across the tracked portfolioKalturaNASDAQ: KLTRRallybio, LLCNASDAQ: RLYBSpire Global IncNYSE: SPIRValens Semiconductor LtdNYSE: VLNMC10acq. by Medidata
Portfolio news
latest coverage across their companies
Proterra · agriinvestor.com · Jul 16, 2026
Mahzi Therapeutics · forbes.com · Jul 13, 2026
Spire · ca.investing.com · Jun 30, 2026
Kaltura · investing.com · Jun 24, 2026
Waypoint Bio · finsmes.com · Jun 2, 2026
Therini Bio · ophthalmologytimes.com · May 21, 2026
Spire Global Inc · investing.com · May 14, 2026
Quralis · nasdaqprivatemarket.com · Apr 3, 2026
Frequently asked questions
- How many investments has Mitsui Global Investment made?
- Mitsui Global Investment has 61 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does Mitsui Global Investment invest at?
- Mitsui Global Investment invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Mitsui Global Investment's typical check size?
- Mitsui Global Investment typically writes checks of $500K – $10M.
- What sectors does Mitsui Global Investment focus on?
- Mitsui Global Investment focuses on AI & Machine Learning, Biotech, Cleantech, Consumer, Data & Infrastructure, Energy, Enterprise Software, FoodTech, Hardware, Healthtech, Medical Devices, New Materials, SaaS, Sector Agnostic, Semiconductors.
- Where is Mitsui Global Investment located?
- Mitsui Global Investment is headquartered in Menlo Park, US.
- Who does Mitsui Global Investment co-invest with?
- Mitsui Global Investment most often shares deals with E12 Venture Capital, Llc, Evolution VC Partners, LionBird, among 88 tracked co-investors.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Chuangdongfang (创东方) is a Shenzhen-based investment firm focused on equity investment in technology and innovation-driven enterprises, engaging in venture, M&A, and industrial investment.
SBI Investment Korea is a Korean asset management firm within the SBI Group that operates venture capital and private equity funds, positioning itself as a 'New Industry Creator'.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.



























